about
A Questionable Indication For ICD Extraction After Successful VT AblationCurrent investigation and management of patients with syncope: results of the European Heart Rhythm Association survey.Multicenter experience with transvenous lead extraction of active fixation coronary sinus leads.Multicenter experience with extraction of the Riata/Riata ST ICD lead.High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.Pacing and implantable cardioverter-defibrillator transvenous lead extraction.Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leadsTransvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature.Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.Subcutaneous implantable cardiac defibrillators: indications and limitations.Efficacy of low interatrial septum and right atrial appendage pacing for prevention of permanent atrial fibrillation in patients with sinus node disease: results from the electrophysiology-guided pacing site selection (EPASS) study.Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II.First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature.EHRA research network surveys: 6 years of EP wires activity.Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.Leadless technology: a new paradigm for cardiac pacing?Overcoming the current issues surrounding device leads: reducing the complications during extraction.Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.Where is the future of cardiac lead extraction heading?Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).EHRA(European Heart Rhythm Association) EP-Wires Surveys: What Is Common Practice In Device Management?Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey.Extraction of the inner coil of a pacemaker lead slid into the pulmonary artery.Effect of left atrial volume and pulmonary vein anatomy on outcome of nMARQ™ catheter ablation of paroxysmal atrial fibrillation.Relationships between cardiac innervation/perfusion imbalance and ventricular arrhythmias: impact on invasive electrophysiological parameters and ablation procedures.Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey.X-ray exposure hazards for physicians performing ablation procedures and device implantation: results of the European Heart Rhythm Association survey.A Leadless Intracardiac Transcatheter Pacing System.Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey.Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association.How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey.[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].Use of fluoroscopy in clinical electrophysiology in Europe: results of the European Heart Rhythm Association Survey.[2015 ESC Guidelines for the management of infective endocarditis].How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the EurTransvenous extraction profile of Riata leads: procedural outcomes and technical complexity of mechanical removal.Right heart failure due to a fistula between a giant aortic pseudoaneurysm and the left atrium: a late complication after cardiovascular surgery.Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.
P50
Q28082167-9393C5CB-9362-4340-AB13-D5755CA46535Q33163563-864DC97A-BAE7-4FB1-B4DD-55FBE2251056Q34203244-EE28F886-60A6-4D02-877D-98AC45CADDF4Q35172843-116BBB2F-EDF2-45AF-9898-E453E0705E9EQ36015217-F1969E44-0089-4FAA-88DE-D37F8CA599A1Q36117217-A03598F3-1F8B-41F3-B73B-366B10737CA8Q37089760-1A32F6DC-7C96-48AA-AEE9-A73C20B06A75Q37533340-0795F083-3FFB-46E4-BE4D-193CEDA1C440Q38052835-90B998CE-BFDC-45E8-8112-BC13AA64399DQ38145058-A33791CD-54BD-4080-8E8D-E1E70675784BQ38283135-109445B7-23FA-4D0F-AEE4-741BA2246E13Q38483930-1656EF65-D947-4F86-88BE-472A665B5498Q38606213-2D28CE58-730F-4977-8D54-B4AD50598421Q38640505-F7C908C2-893F-4420-BF73-5DC7719D7011Q38641200-52B121CC-6073-4D17-95F7-45AD6BFDA14FQ38659436-749EB3C9-51B2-4C09-9F1A-737B8240D78CQ38659445-973C76CE-7ECE-4645-87D0-84E6FACDFE91Q38682204-B4951456-03C7-41B8-BC20-BA2063AF54E8Q38743440-3574CB38-073B-4810-987A-1D5277E8EB01Q38834180-D4A8E1E4-AAF9-4010-88AF-5F298DC51901Q38844635-C6AD0BEF-3DAA-4B6F-B287-393D177ECD19Q39037035-B8948C76-6E0A-40F9-B675-8935E473AC69Q39108139-1B4F8DA1-E83A-449A-AB16-3BA689BC4BE7Q39213677-45F83F8E-34A6-4879-8C41-D26C67BA20CCQ39313870-FC50DB5E-A074-4383-9531-CE83210F944FQ39588281-20EB75D3-14DA-4F51-B72D-9EDAB75645AAQ39613935-67A0B3E9-DF74-494D-BEA4-68C9C8ECF86BQ40090794-A19A9B97-F6AF-4926-864F-CF831816E5A9Q40340789-8F886320-C469-42E4-BB9E-59503D9FAEB3Q40395895-3BC77D34-283A-4E2C-B333-2058E5637C47Q40436875-DD5A8CAF-0A49-4437-BF7A-4F8FBDD7620BQ40458916-701CEEAD-3E5A-4DE9-BFEB-ABAE4FB144FEQ40708266-72B6DBAB-E058-493D-A463-9EB698267AE2Q40791396-68C59B7D-6603-4B68-996F-4ACE258C5E5CQ40846975-E025CC62-FC49-4FBB-AF5D-A075951E107CQ40891218-1FDCFEDF-A5F6-4F15-AB7A-76ED8C02B1DCQ41026009-E32B9248-752F-4A7C-955F-1A4C6EB39079Q41699736-83BD5AE5-0545-415F-AE82-FCDA8DDD1256Q42210335-39DE0CB8-5566-468D-9A0D-10C65DAF0525Q42248546-B851F690-C967-420D-95B6-A02A2D0CCF5D
P50
name
Maria Grazia Bongiorni
@en
Maria Grazia Bongiorni
@nl
type
label
Maria Grazia Bongiorni
@en
Maria Grazia Bongiorni
@nl
prefLabel
Maria Grazia Bongiorni
@en
Maria Grazia Bongiorni
@nl